Somewhat Favorable News Coverage Somewhat Unlikely to Affect Tekla Healthcare Investors (HQH) Stock Price

Media stories about Tekla Healthcare Investors (NYSE:HQH) have trended somewhat positive this week, Accern reports. The research group identifies negative and positive press coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Tekla Healthcare Investors earned a media sentiment score of 0.21 on Accern’s scale. Accern also gave headlines about the financial services provider an impact score of 46.0571904677292 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

Shares of Tekla Healthcare Investors (NYSE HQH) opened at $22.05 on Friday. Tekla Healthcare Investors has a 52 week low of $20.84 and a 52 week high of $26.37.

The company also recently declared a quarterly dividend, which will be paid on Friday, December 29th. Stockholders of record on Tuesday, November 28th will be paid a dividend of $0.52 per share. This is a positive change from Tekla Healthcare Investors’s previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Monday, November 27th. This represents a $2.08 annualized dividend and a dividend yield of 9.43%.

COPYRIGHT VIOLATION WARNING: This article was originally posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this article on another publication, it was copied illegally and republished in violation of United States and international copyright legislation. The original version of this article can be read at https://www.dispatchtribunal.com/2017/12/08/somewhat-favorable-news-coverage-somewhat-unlikely-to-affect-tekla-healthcare-investors-hqh-stock-price.html.

Tekla Healthcare Investors Company Profile

Tekla Healthcare Investors is a non-diversified closed-end healthcare fund. The Fund’s investment objective is to seek long-term capital appreciation by investing primarily in securities of healthcare companies. It seeks to provide regular distribution of realized capital gains. It may invest up to 20% of its net assets in securities of foreign issuers, located primarily in Western Europe, Canada and Japan, and securities of United States issuers that are traded in foreign markets.

Insider Buying and Selling by Quarter for Tekla Healthcare Investors (NYSE:HQH)

Receive News & Ratings for Tekla Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tekla Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply